InfoSynergy
Calcium
Calcium may be used to correct or prevent cinacalcet-related hypocalcemia when prescribed.
Recommendation: Do not self-adjust calcium; follow calcium, phosphate, and PTH monitoring instructions.
Cinacalcet
Prescription ·Strong evidence ·Reviewed May 2026
Cinacalcet is an oral calcimimetic used for secondary hyperparathyroidism in adults on dialysis and for hypercalcemia in parathyroid carcinoma or selected primary hyperparathyroidism patients. It lowers parathyroid hormone and serum calcium, so hypocalcemia, QT prolongation from hypocalcemia, seizures, and worsening heart failure symptoms are key safety concerns.
What it's good for
The bottom line
Evidence rating strong. Most-documented uses: reduced pth in dialysis-related secondary hyperparathyroidism, reduced hypercalcemia in parathyroid carcinoma, reduced serum calcium in selected primary hyperparathyroidism when surgery is not appropriate. 3 sources indexed (2012–2026), with 4 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
Cinacalcet allosterically increases sensitivity of the calcium-sensing receptor on parathyroid cells to extracellular calcium. This suppresses parathyroid hormone secretion, which lowers serum calcium and can lower phosphorus in some settings. Metabolism involves CYP3A4, CYP2D6, and CYP1A2, and calcium changes require close biochemical monitoring.3,1
Class
Calcimimetic calcium-sensing receptor agonist
Absorption
Water-soluble; take with food
Dosing
Dosing & protocol.
Common range
Secondary hyperparathyroidism in adults on dialysis: start 30 mg orally once daily and titrate every 2 to 4 weeks by PTH and calcium. Parathyroid carcinoma or primary hyperparathyroidism: often 30 mg twice daily initially, titrated to calcium response.
Recommended form
Oral tablet taken with food or shortly after a meal
Take with food or shortly after a meal to improve exposure. Do not start if corrected serum calcium is below the lower limit of normal.
Depletions
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Calcium
SignificantCinacalcet intentionally lowers PTH and serum calcium and can cause clinically significant hypocalcemia.
Replace CalciumMonitor Corrected serum calciumOnset Days to weeks, especially after initiation or dose increase
Safety
Full safety detail.
Side effects
- Nausea
- Vomiting
- Diarrhea
- Myalgia
- Dizziness
- Hypocalcemia
- Paresthesias
- Seizures in susceptible patients
- QT prolongation secondary to hypocalcemia
- Hypotension or worsening heart failure symptoms
- Adynamic bone disease if PTH is oversuppressed
Interactions
Interaction records.
ModerateSynergy
Vitamin D3
Vitamin D therapy can help maintain calcium balance but can also change calcium and phosphate response during cinacalcet treatment.
Recommendation: Use only as directed and monitor calcium, phosphorus, and PTH after changes.
ModerateCaution
Magnesium Glycinate
Low magnesium can worsen neuromuscular irritability and arrhythmia risk when hypocalcemia occurs, but supplementation in kidney disease requires caution.
Recommendation: Correct magnesium only with clinician guidance, especially in dialysis or low kidney function.
ModerateConflict
St. John's Wort
St. John's Wort can induce CYP3A4 and may reduce cinacalcet exposure, destabilizing calcium and PTH control.
Recommendation: Avoid unsupervised use; recheck labs if any enzyme-inducing supplement is started or stopped.
Sources
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Randomized controlled trials
1- 1Effect of cinacalcet on cardiovascular disease in patients undergoing dialysisNeeds reviewNo linkEVOLVE Trial Investigators · New England Journal of Medicine · 2012
Large outcomes trial informs benefits and limitations of cinacalcet in dialysis-related secondary hyperparathyroidism.
Reviews & position papers
1- 2KDIGO 2017 Clinical Practice Guideline Update for CKD-MBDNeeds reviewNo linkKidney Disease: Improving Global Outcomes · Kidney International Supplements · 2017
Guideline supports individualized use of calcimimetics and avoidance of hypocalcemia or oversuppressed PTH.
Reference material
1- 3Cinacalcet Tablets US Prescribing InformationNeeds reviewURLU.S. National Library of Medicine · DailyMed · 2026
Labeling describes dosing, contraindication to initiation with low calcium, monitoring for hypocalcemia, and CYP interactions.
Keep exploring
Deep dives & adjacent profiles.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Cinacalcet in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.